生命科学资讯

Vir climbs on Astellas deal, study results for ‘masked’ T cell engager

Astellas and Vir in $1.3B deal for CD3 T-cell engager

Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies

Galapagos takes €228M hit from cell therapy wind-down but still has cash for dealmaking

Single Cell Multiomics Market Is Going to Boom |• 10x Genomics • Illumina - openPR.com

Gilead brings Arcellx fully under the fold

Gilead to buy Arcellx in $7.8B wager on multiple myeloma cell therapy

Gilead to acquire cell therapy partner Arcellx for $7.8B

All about cell therapy process characterization

Structure of the lysosomal KICSTOR-GATOR1-SAMTOR nutrient-sensing supercomplex

Symbiotic entrenchment through ecological Catch-22

Unified modeling of 3D molecular generation via atomic interactions with PocketXMol

A circadian rheostat drives proton electrochemical gradients to optimize cell-type-specific growth in Arabidopsis

Brain-wide mapping of oligodendrocyte organization, oligodendrogenesis, and myelin injury

Tuning the sensitivity of mechanosensory receptors through histidine scanning

Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature

Implanted flexible electronics reveal principles of human islet cell electrical maturation | Science

$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance

J&J pours $1B into new cell therapy site in Pennsylvania

T cells store lipids and die in rheumatoid arthritis joints